COVID-19 vaccination: blood clotting information for healthcare professionals
Information for healthcare professionals on blood clotting following COVID-19 vaccination.
Applies to England
Documents
Details
Information for healthcare professionals on blood clotting following coronavirus (COVID-19) vaccination.
This publication is subject to extensive and regular revisions and we recommend linking to the latest version to ensure that you are giving the most up-to-date clinical advice and guidance.
Updates to this page
Published 7 April 2021Last updated 14 February 2022 + show all updates
-
Updated to include information on the risk of relapse of thrombosis and thrombocytopenia symptoms and risk of new or relapse of immune thrombocytopenic purpura following COVID-19 vaccinations.
-
Added print version.
-
Updated guidance document.
-
Updated to include: antiphospholipid syndrome, interchangeability of COVID-19 vaccines, samples required for whole genome sequencing and the latest MHRA data.
-
Updated information for healthcare professionals on blood clotting following COVID-19 vaccination.
-
Updated sections: 13, 14, 16, 17, 19, 21 and 22.
-
Added print version.
-
First published.